Spectrophotometric method for determination of bifunctional macrocyclic ligands in macrocyclic ligand-protein conjugates

Nuclear Medicine and Biology

Volumn 26, Issue 8, 1999, Pages 977-982

  Dadachova, E ^a   Chappell, L L ^a   Brechbiel, M W ^a  

^a Radiat Oncol Br Natl Cancer I   (United States)

Author keywords

Antibodies; Conjugates; Polyazamacrocycles; Radioimmunotherapy; Radiolabel ing; Spectrophotometry

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; ACETIC ACID DERIVATIVE; ARSENIC DERIVATIVE; CARBOXYLIC ACID DERIVATIVE; LEAD; LIGAND; MACROCYCLIC COMPOUND;

ARTICLE; BINDING AFFINITY; CHELATION; COMPLEX FORMATION; DRUG CONJUGATION; DRUG DETERMINATION; DRUG PROTEIN BINDING; SPECTRAL SENSITIVITY; SPECTROPHOTOMETRY;

ANTIBODIES, MONOCLONAL; CHELATING AGENTS; INDICATORS AND REAGENTS; ISOTHIOCYANATES; LEAD; LEAD RADIOISOTOPES; POLYCYCLIC COMPOUNDS; PROTEINS; SPECTROPHOTOMETRY, INFRARED;

EID: 0033380104     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(99)00054-2     Document Type: Article

References (23)

1. Anderson C. J., Connett J. M., Guo L. W., Schwarz S. W., Philpott G. W., Zinn K. R. and Welch M. J. (1994) Initial comparison of Cu-67 and Cu-64-labeled anti-colorectal carcinoma Mab 1A3 as agents for radioimmunotherapy in tumor-bearing hamsters. J. Nucl. Med. 35, 161P.
2. Chappell L. L., Buck E. R., Khazaeli M. B., Matthew S. M., Buchsbaum D. J. and Brechbiel M. W. (In press) Improved synthesis of the bifunctional chelating agent 1, 4, 7, 10-tetraaza-N-(1-carboxy-3- (4-nitrophenyl)propyl)-N′,N″,N‴-tris(acetic acid)cyclododecane (PA-DOTA). Bioorg. Med. Chem.
3. 205/6Bi labeled monoclonal antibodies 2-(p-SCN-Bz)-PEPA. Manuscript in preparation.
4. 203Pb labeled monoclonal antibodies 2-(p-SCN-Bz)-TCMC. Nucl. Med. Biol (submitted).
5. Chaves S., Delgado R., Frausto Da Silva J.J.R. The stability of metal complexes of cyclic tetraaza tetraacetic acid. Talanta. 39:1992;249-254.
6. Cole W.C., De Nardo S.J., Mears C.F. Serum stability of Cu-67 chelates Comparison with In-111 and Co-57 . Nucl. Med. Biol. 13:1986;363-368.
7. Deal K. A., Davis I. A., Mirzadeh S., Kennel S. J., and Brechbiel M. W. (1999) Improved in vivo stability of actinium-225 macrocyclic complexes. J. Med. Chem. 42, 2988-2992.
8. Feng X., Pak R.H., Kroger L.A., Moran J.K., De Nardo D.G., Mears C.F., De Nardo G.L., De Nardo S.J. New anti-Cu-TETA and anti-Y-DOTA monoclonal antibodies for potential use in the pre-targeted delivery of radiopharmaceuticals to tumor. Hybridoma. 17:1998;125-132.
9. 203Pb using a lead-selective extraction chromatographic resin. Appl. Radiat. Isot. 49:1998;357-359.
10. Horak E., Hartmann F., Garmestani K., Wu C., Brechbiel M., Gansow O.A., Landolfi N.F., Waldmann T.A. Radioimmunotherapy targeting of HER2/neu oncoprotein on ovarian tumor using lead-212-DOTA-AE1. J. Nucl. Med. 38:1997;1944-1950.
11. Krejcarek G.E., Tucker K.L. Covalent attachment of chelating groups to macromolecules. Biochem. Biophys. Res. Commun. 77:1977;581-585.
12. Lewis M.R., Raubitschek A., Shively L.E. A facile, water-soluble method for modification of proteins with DOTA. Use of elevated temperature and optimized pH to achieve high specific activity and high chelate stability in radiolabeled immuno-conjugates. Bioconjugate Chem. 5:1994;565-576.
13. McMurry T.J., Brechbiel M., Kumar K., Gansow O.A. Convenient synthesis of bifunctional tetraaza macrocycles. Bioconjugate Chem. 3:1992;108-117.
14. Mathias C.J., Sun Y., Connett J.M., Philpott G.W., Welch M.J., Martell A.E. A new bifunctional chelate, BrMe2HBED An effective conjugate for radiometals and antibodies . Inorg. Chem. 29:1990;1475-1480.
15. Meares C.F., McCall M.J., Reardan D.T., Goodwin D.A., Diamanti C.I., McTigue M. Conjugation of antibodies with bifunctional chelating agents Isothiocyanate and bromoacetamide reagents, methods of analysis and subsequent addition of metal ions . Anal. Biochem. 142:1984;68-78.
16. Meares C.F., Moi M.K., Diril H., Kukis D.L., McCall M.J., Deshpande S.V., De Nardo S.J., Snook D., Epenetos A.A. Macrocyclic chelates for radiometals for diagnosis and therapy. Br. J. Cancer. 62:1990;21-26.
17. Milenic D.E., Roselli M., Brechbiel M.W., Pippin C.G., McMurry T.J., Carrasquillo J.A., Colcher D., Lambrecht R., Gansow O.A., Schlom J. In vivo evaluation of a lead-labeled monoclonal antibody using the DOTA ligand. Eur. J. Nucl. Med. 25:1995;471-480.
18. Moi M.K., Meares C.F., McCall M.J., Cole W.C., De Nardo S.J. Copper chelates as probes of biological systems Stable copper complexes with a macrocyclic bifunctional chelating agent . Anal. Biochem. 148:1985;249-253.
19. 203Pb labeled monoclonal antibodies . Inorg. Chim. Acta. 239:1995;43-51.
20. Pippin C.G., Parker T.A., McMurry T.J., Brechbiel M.W. Spectrophotometric method for the determination of a bifunctional DTPA ligand in DTPA-monoclonal antibody conjugates. Bioconjugate Chem. 3:1992;342-345.
21. Savvin S.B. Analytical use of Arsenazo III. Talanta. 8:1961;673-685.
22. 177Lutetium-labeled immunoconjugate. Cancer Res. 51:1991;2889-2896.
23. Waldmann T.A. Monoclonal antibodies in diagnosis and therapy. Science. 252:1991;1657-1662.